An open randomised clinical study comparing Arimidex (TM) [anastrozole] with Nolvadex (TM) [tamoxifen] as adjuvant therapies in post-menopausal women with breast cancer already being treated with Nolvadex for at least two years
Latest Information Update: 26 Jul 2013
At a glance
- Drugs Anastrozole (Primary) ; Tamoxifen
- Indications Early breast cancer
- Focus Therapeutic Use
- Acronyms ITA
- 12 Nov 2008 Actual patient number identified as 448 from ClinicalTrials.gov.
- 12 Nov 2008 Actual trial completion date identified as May 2006 from ClinicalTrials.gov.
- 12 Nov 2008 Status changed from active, no longer recruiting to completed according to ClinicalTrials.gov.